ATE423200T1 - Neues plexin-polypeptid, dieses codierende dna und verwendung davon - Google Patents

Neues plexin-polypeptid, dieses codierende dna und verwendung davon

Info

Publication number
ATE423200T1
ATE423200T1 AT04793105T AT04793105T ATE423200T1 AT E423200 T1 ATE423200 T1 AT E423200T1 AT 04793105 T AT04793105 T AT 04793105T AT 04793105 T AT04793105 T AT 04793105T AT E423200 T1 ATE423200 T1 AT E423200T1
Authority
AT
Austria
Prior art keywords
polypeptide
seq
dna
amino acid
acid sequence
Prior art date
Application number
AT04793105T
Other languages
English (en)
Inventor
Hisashi Koga
Osamu Ohara
Haruhiko Koseki
Mitsuhiro Okada
Akiyoshi Uemura
Hiroki Arakawa
Mitsuhiro Tada
Original Assignee
Kazusa Dna Res Inst Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kazusa Dna Res Inst Foundation filed Critical Kazusa Dna Res Inst Foundation
Application granted granted Critical
Publication of ATE423200T1 publication Critical patent/ATE423200T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04793105T 2003-10-30 2004-10-28 Neues plexin-polypeptid, dieses codierende dna und verwendung davon ATE423200T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003371040 2003-10-30
JP2004229871 2004-08-05

Publications (1)

Publication Number Publication Date
ATE423200T1 true ATE423200T1 (de) 2009-03-15

Family

ID=34680588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04793105T ATE423200T1 (de) 2003-10-30 2004-10-28 Neues plexin-polypeptid, dieses codierende dna und verwendung davon

Country Status (6)

Country Link
US (2) US7482322B2 (de)
EP (1) EP1679372B1 (de)
JP (1) JP4751202B2 (de)
AT (1) ATE423200T1 (de)
DE (1) DE602004019556D1 (de)
WO (1) WO2005056791A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1907420T3 (en) 2005-07-21 2017-07-17 Modiquest B V PLEXIN D1 TARGETED FOR TUMOR DIAGNOSTICATION AND TUMOR THERAPY
EP2385121A1 (de) 2010-05-06 2011-11-09 Netris Pharma Antagonisten der Sema3E/PlexinD1-Interaktion als Antikrebswirkstoff

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63203626A (ja) * 1987-02-19 1988-08-23 Ajinomoto Co Inc 免疫抑制剤
AU7073800A (en) 1999-08-25 2001-03-19 Regents Of The University Of California, The Novel plexins and uses thereof
AU2001243142A1 (en) 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
JP4711520B2 (ja) 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7892730B2 (en) * 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
WO2002081745A2 (en) * 2001-04-05 2002-10-17 Proskelia Pharmaceuticals Genes involved in osteogenesis, and methods of use
EP1504099A4 (de) * 2001-12-10 2006-05-10 Nuvelo Inc Neue nukleinsäuren und polypeptide
JP2005523688A (ja) * 2002-01-18 2005-08-11 ブリストル−マイヤーズ　スクイブ　カンパニー タンパク質チロシンキナーゼおよび／またはタンパク質チロシンキナーゼ経路と相互作用する化合物の活性を予測するためのポリヌクレオチドおよびポリペプチドの同定
WO2003068268A2 (en) * 2002-02-14 2003-08-21 Bioinvent International Ab Treatment, diagnosis and imaging of disease
US20040101874A1 (en) * 2002-04-12 2004-05-27 Mitokor Inc. Targets for therapeutic intervention identified in the mitochondrial proteome
EP1576137A4 (de) * 2002-10-29 2010-06-30 Genentech Inc Zusammensetzungen und verfahren für die behandlung von immunkrankheiten
AU2003295401B2 (en) * 2002-11-08 2010-04-29 Genentech, Inc. Compositions and methods for the treatment of natural killer cell related diseases
AU2003292231A1 (en) * 2002-12-12 2004-06-30 Novartis Ag Methods for diagnosing and treating schizophrenia
EP1611900A1 (de) * 2003-03-19 2006-01-04 Dnavec Research Inc. Verfahren zur behandlung von entzündungskrankheiten in zusammenhang mit knochendestruktion

Also Published As

Publication number Publication date
DE602004019556D1 (de) 2009-04-02
EP1679372A4 (de) 2006-11-08
US20070212365A1 (en) 2007-09-13
EP1679372B1 (de) 2009-02-18
EP1679372A1 (de) 2006-07-12
JPWO2005056791A1 (ja) 2007-12-06
US7482322B2 (en) 2009-01-27
US7816132B2 (en) 2010-10-19
WO2005056791A1 (ja) 2005-06-23
US20090215170A1 (en) 2009-08-27
JP4751202B2 (ja) 2011-08-17

Similar Documents

Publication Publication Date Title
ATE430197T1 (de) Fibroblasten wachstumsfaktor-ähnliche polypeptide
UA48105C2 (uk) ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
DK1294876T3 (da) EV-VEGF-nukleinsyrer og -polypeptider samt fremgangsmåder til deres benyttelse
ATE540973T1 (de) Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung
ATE182901T1 (de) Für androgen-rezeptor-protein kodierende dna
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
WO2006042719A3 (de) Polypeptid mit phytaseaktivität und dieses codierende nucleotidsequenz
DE602004019556D1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
EP2354156A3 (de) Nukleinsäuren und Proteine von Insekten OR83B-Duftrezeptorgenen und Verwendungen davon
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
MXPA05009954A (es) Familia de proteinas secretadas.
WO2003031566A3 (en) Keratinocyte derived interferon
ATE390481T1 (de) Modifizierte tridegine, ihre herstellung und verwendung als transglutaminase-inhibitoren
ATE411338T1 (de) Nukleinsäuremolekül, umfassend eine für ein hämocyanin kodierende nukleinsäuresequenz und mindestens eine intronsequenz
DK1241179T3 (da) Humant protein med in vitro antiproliferativ aktivitet.
ATE415422T1 (de) Menschliches gas-6 (growth arrest-specific gene 6) protein und dafür kodierende nukleinsäuren
EP1568775A4 (de) Krebs-assoziiertes gen
DE60237236D1 (de) Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür
WO2003074675A3 (en) Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
RU2008130819A (ru) Способ продукции рекомбинантной стафилокиназы при регулировании уровня кислорода
ATE380864T1 (de) Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure
WO2000063370A3 (en) Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
ATE402954T1 (de) Menschliches a33-antigen-ähnliches protein und dafür kodierende nukleinsäure
ATE405590T1 (de) Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties